Skip to content
CNS Clinical Research

Idaho

CNS clinical trials in Idaho

19 CNS studies are recruiting participants at sites in 6 cities across Idaho as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Idaho city with a recruiting study

By research area: Depression (7), Epilepsy (4), Migraine (4), Parkinson's Disease (3), Multiple Sclerosis (1).

Boise (11), Meridian (3), Coeur d'Alene (2), Idaho Falls (1), Post Falls (1), Saint Maries (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Idaho

Basic details from each study's public record (the 12 most recently updated of 19). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Maternal Stress on Human Milk and Infant Outcomes

    • No phase
    • Ages 18 to 50
    • Female participants
    Sponsor
    University of Idaho
    Recruiting in
    Coeur d'Alene
    Registry record
    NCT04821544 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Boise
    Registry record
    NCT06748222 · updated
  3. A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Saint Maries
    Registry record
    NCT07716098 · updated
  4. Study of ALTO-300 in MDD

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alto Neuroscience
    Recruiting in
    Boise
    Registry record
    NCT05922878 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Idaho on ClinicalTrials.gov.

Parkinson's disease: recently updated in Idaho

  1. Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Recruiting in
    Boise
    Registry record
    NCT02071134 · updated
  2. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Boise
    Registry record
    NCT06841354 · updated
  3. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Post Falls
    Registry record
    NCT06623422 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Idaho on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Idaho

  1. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Recruiting in
    Coeur d'Alene
    Registry record
    NCT06433752 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Idaho on ClinicalTrials.gov.

Epilepsy: recently updated in Idaho

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Boise
    Registry record
    NCT07563881 · updated
  2. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Recruiting in
    Boise
    Registry record
    NCT05667142 · updated
  3. A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Recruiting in
    Boise
    Registry record
    NCT05716100 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Idaho on ClinicalTrials.gov.

Migraine: recently updated in Idaho

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Boise
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Idaho on ClinicalTrials.gov.

Ask about studies in Idaho

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call